vs
Claritev Corp(CTEV)与LifeStance Health Group, Inc.(LFST)财务数据对比。点击上方公司名可切换其他公司
LifeStance Health Group, Inc.的季度营收约是Claritev Corp的1.6倍($382.2M vs $246.6M),LifeStance Health Group, Inc.净利率更高(3.1% vs -32.7%,领先35.7%),LifeStance Health Group, Inc.同比增速更快(17.4% vs 6.2%),LifeStance Health Group, Inc.自由现金流更多($46.6M vs $36.4M),过去两年LifeStance Health Group, Inc.的营收复合增速更高(12.8% vs 2.5%)
LifeStance Health Group是美国的门诊行为健康服务提供商,支持线下面诊与远程诊疗两种服务模式,业务涵盖心理咨询、精神科诊疗、经颅磁刺激(TMS)以及氯胺酮治疗等。该公司曾多次因劳动违规、客户信息泄露及误导投资者相关问题遭遇诉讼。
CTEV vs LFST — 直观对比
营收规模更大
LFST
是对方的1.6倍
$246.6M
营收增速更快
LFST
高出11.2%
6.2%
净利率更高
LFST
高出35.7%
-32.7%
自由现金流更多
LFST
多$10.3M
$36.4M
两年增速更快
LFST
近两年复合增速
2.5%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $246.6M | $382.2M |
| 净利润 | $-80.6M | $11.7M |
| 毛利率 | — | — |
| 营业利润率 | -3.1% | 4.7% |
| 净利率 | -32.7% | 3.1% |
| 营收同比 | 6.2% | 17.4% |
| 净利润同比 | 41.6% | 264.1% |
| 每股收益(稀释后) | $-4.88 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
CTEV
LFST
| Q4 25 | $246.6M | $382.2M | ||
| Q3 25 | $246.0M | $363.8M | ||
| Q2 25 | $241.6M | $345.3M | ||
| Q1 25 | $231.3M | $333.0M | ||
| Q4 24 | $232.1M | $325.5M | ||
| Q3 24 | $230.5M | $312.7M | ||
| Q2 24 | $233.5M | $312.3M | ||
| Q1 24 | $234.5M | $300.4M |
净利润
CTEV
LFST
| Q4 25 | $-80.6M | $11.7M | ||
| Q3 25 | $-69.8M | $1.1M | ||
| Q2 25 | $-62.6M | $-3.8M | ||
| Q1 25 | $-71.3M | $709.0K | ||
| Q4 24 | $-138.0M | $-7.1M | ||
| Q3 24 | $-391.4M | $-6.0M | ||
| Q2 24 | $-576.7M | $-23.3M | ||
| Q1 24 | $-539.7M | $-21.1M |
营业利润率
CTEV
LFST
| Q4 25 | -3.1% | 4.7% | ||
| Q3 25 | 4.1% | 2.0% | ||
| Q2 25 | 6.9% | -0.9% | ||
| Q1 25 | 4.2% | 0.5% | ||
| Q4 24 | -17.8% | 0.3% | ||
| Q3 24 | -146.7% | 0.0% | ||
| Q2 24 | -224.4% | -5.1% | ||
| Q1 24 | -207.4% | -5.6% |
净利率
CTEV
LFST
| Q4 25 | -32.7% | 3.1% | ||
| Q3 25 | -28.4% | 0.3% | ||
| Q2 25 | -25.9% | -1.1% | ||
| Q1 25 | -30.8% | 0.2% | ||
| Q4 24 | -59.4% | -2.2% | ||
| Q3 24 | -169.8% | -1.9% | ||
| Q2 24 | -247.0% | -7.5% | ||
| Q1 24 | -230.1% | -7.0% |
每股收益(稀释后)
CTEV
LFST
| Q4 25 | $-4.88 | — | ||
| Q3 25 | $-4.23 | — | ||
| Q2 25 | $-3.81 | — | ||
| Q1 25 | $-4.38 | — | ||
| Q4 24 | $-8.49 | — | ||
| Q3 24 | $-24.25 | — | ||
| Q2 24 | $-35.78 | — | ||
| Q1 24 | $-33.40 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $16.8M | $248.6M |
| 总债务越低越好 | $4.6B | $282.8M |
| 股东权益账面价值 | $-173.9M | $1.5B |
| 总资产 | $4.9B | $2.2B |
| 负债/权益比越低杠杆越低 | — | 0.19× |
8季度趋势,按日历期对齐
现金及短期投资
CTEV
LFST
| Q4 25 | $16.8M | $248.6M | ||
| Q3 25 | $39.2M | $203.9M | ||
| Q2 25 | $56.4M | $188.9M | ||
| Q1 25 | $23.1M | $134.3M | ||
| Q4 24 | $16.8M | $154.6M | ||
| Q3 24 | $86.6M | $102.6M | ||
| Q2 24 | $48.8M | $87.0M | ||
| Q1 24 | $58.7M | $49.5M |
总债务
CTEV
LFST
| Q4 25 | $4.6B | $282.8M | ||
| Q3 25 | $4.5B | $284.6M | ||
| Q2 25 | $4.5B | $286.4M | ||
| Q1 25 | $4.5B | $288.2M | ||
| Q4 24 | $4.5B | $290.0M | ||
| Q3 24 | $4.5B | $287.3M | ||
| Q2 24 | $4.5B | $288.0M | ||
| Q1 24 | $4.5B | $288.8M |
股东权益
CTEV
LFST
| Q4 25 | $-173.9M | $1.5B | ||
| Q3 25 | $-101.8M | $1.5B | ||
| Q2 25 | $-39.9M | $1.5B | ||
| Q1 25 | $14.8M | $1.5B | ||
| Q4 24 | $84.0M | $1.4B | ||
| Q3 24 | $207.6M | $1.4B | ||
| Q2 24 | $603.4M | $1.4B | ||
| Q1 24 | $1.2B | $1.4B |
总资产
CTEV
LFST
| Q4 25 | $4.9B | $2.2B | ||
| Q3 25 | $5.0B | $2.1B | ||
| Q2 25 | $5.1B | $2.1B | ||
| Q1 25 | $5.1B | $2.1B | ||
| Q4 24 | $5.2B | $2.1B | ||
| Q3 24 | $5.3B | $2.1B | ||
| Q2 24 | $5.7B | $2.1B | ||
| Q1 24 | $6.4B | $2.1B |
负债/权益比
CTEV
LFST
| Q4 25 | — | 0.19× | ||
| Q3 25 | — | 0.19× | ||
| Q2 25 | — | 0.19× | ||
| Q1 25 | 304.87× | 0.20× | ||
| Q4 24 | 53.67× | 0.20× | ||
| Q3 24 | 21.73× | 0.20× | ||
| Q2 24 | 7.48× | 0.20× | ||
| Q1 24 | 3.85× | 0.20× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $66.3M | $57.6M |
| 自由现金流经营现金流 - 资本支出 | $36.4M | $46.6M |
| 自由现金流率自由现金流/营收 | 14.8% | 12.2% |
| 资本支出强度资本支出/营收 | 12.1% | 2.9% |
| 现金转化率经营现金流/净利润 | — | 4.93× |
| 过去12个月自由现金流最近4个季度 | $-12.3M | $110.0M |
8季度趋势,按日历期对齐
经营现金流
CTEV
LFST
| Q4 25 | $66.3M | $57.6M | ||
| Q3 25 | $19.9M | $27.3M | ||
| Q2 25 | $61.2M | $64.4M | ||
| Q1 25 | $-30.1M | $-3.1M | ||
| Q4 24 | $-33.4M | $62.3M | ||
| Q3 24 | $72.8M | $22.7M | ||
| Q2 24 | $18.5M | $44.1M | ||
| Q1 24 | $49.7M | $-21.8M |
自由现金流
CTEV
LFST
| Q4 25 | $36.4M | $46.6M | ||
| Q3 25 | $-16.3M | $17.0M | ||
| Q2 25 | $36.6M | $56.6M | ||
| Q1 25 | $-68.9M | $-10.3M | ||
| Q4 24 | $-63.8M | $56.0M | ||
| Q3 24 | $41.1M | $17.7M | ||
| Q2 24 | $-7.0M | $39.0M | ||
| Q1 24 | $19.2M | $-26.9M |
自由现金流率
CTEV
LFST
| Q4 25 | 14.8% | 12.2% | ||
| Q3 25 | -6.6% | 4.7% | ||
| Q2 25 | 15.2% | 16.4% | ||
| Q1 25 | -29.8% | -3.1% | ||
| Q4 24 | -27.5% | 17.2% | ||
| Q3 24 | 17.8% | 5.7% | ||
| Q2 24 | -3.0% | 12.5% | ||
| Q1 24 | 8.2% | -9.0% |
资本支出强度
CTEV
LFST
| Q4 25 | 12.1% | 2.9% | ||
| Q3 25 | 14.7% | 2.8% | ||
| Q2 25 | 10.2% | 2.2% | ||
| Q1 25 | 16.8% | 2.2% | ||
| Q4 24 | 13.1% | 1.9% | ||
| Q3 24 | 13.8% | 1.6% | ||
| Q2 24 | 10.9% | 1.6% | ||
| Q1 24 | 13.0% | 1.7% |
现金转化率
CTEV
LFST
| Q4 25 | — | 4.93× | ||
| Q3 25 | — | 25.34× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | -4.36× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图